位置:成果数据库 > 期刊 > 期刊详情页
扩增阻滞突变系统法检测非小细胞肺癌微小标本表皮生长因子受体突变
  • ISSN号:1000-7431
  • 期刊名称:肿瘤
  • 时间:2012.11.5
  • 页码:929-935
  • 分类:R734.2[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]同济大学附属上海市肺科医院肺癌免疫实验室同济大学医学院肿瘤研究所,上海200433
  • 相关基金:国家自然科学基金资助项目(编号:81172101)
  • 相关项目:miR-21在非小细胞肺癌EGFR-TKI耐药中的作用和分子机制研究
中文摘要:

目的 :探索微RNA-21(micro RNA-21,mi R-21)以及与Bcl-2相互作用的细胞死亡调节子(Bcl-2 interacting mediator of cell death,BIM)蛋白在人肺腺癌细胞发生表皮生长因子受体(epidermal growth factor receptor,EGFR)-酪氨酸激酶抑制剂(tyrosine kinase inhibitors,TKIs)获得性耐药过程中的作用及调控关系。方法 :将重组质粒pc DNA3.1-BIM和空质粒pc DNA3.1分别瞬时转染至吉非替尼耐药的肺腺癌细胞株PC9R中,采用实时荧光定量PCR法检测各组细胞中mi R-21的表达水平,细胞计数试剂盒-8(cell counting kit-8,CCK-8)法检测PC9R细胞对吉非替尼的敏感性变化。同时,采用慢病毒感染的方法干扰PC9R细胞株中mi R-21的表达,然后采用实时荧光定量PCR法和蛋白质印迹法检测细胞中BIM基因的表达水平,CCK-8法检测PC9R细胞对吉非替尼的敏感性变化。另外,在干扰mi R-21表达的PC9R细胞中转染pc DNA3.1-BIM重组质粒,然后采用CCK-8法检测PC9R细胞对吉非替尼的敏感性变化。结果 :重组质粒pc DNA3.1-BIM转染后,PC9R细胞中BIM的表达水平明显提高(P〈0.01),mi R-21的表达水平也相应升高(P〈0.01)。慢病毒干扰mi R-21表达后,PC9R细胞中mi R-21的表达水平明显降低(P〈0.05),BIM的表达水平也相应降低(P〈0.05)。下调mi R-21水平和上调BIM表达均能提高PC9R细胞对吉非替尼的敏感性(P值均〈0.05),而在下调mi R-21表达的同时上调BIM表达,更加提高了细胞对吉非替尼的敏感性(P〈0.05)。结论 :mi R-21和BIM基因在逆转吉非替尼耐药过程中可能起关键作用,并且二者存在相互拮抗的作用。

英文摘要:

Objective: To investigate the effect and interaction of micro RNA-21(miR-21) and Bcl-2 interacting mediator of cell death(BIM) on acquired drug resistance to epidermal growth factor receptor(EGFR)-tyrosine kinase inhibitors(TKIs) in human lung adenocarcinoma cells.Methods: The empty plasmid pc DNA3.1 and recombinant plasmid pc DNA3.1-BIM were transiently transfected into gefitinib-resistant human lung adenocarcinoma PC9R cells, respectively, then the expression of miR-21 was determined by real-time fluorescent quantitative-PCR(RFQ-PCR), and the proliferation of PC9R cells treated with gefitinib was detected by cell counting kit-8(CCK-8) assay. Meanwhile, the expression of miR-21 in PC9R cells was interfered by lentivirus infection method, then BIM expression and cell proliferation were detected by RFQ-PCR, Western blotting and CCK-8 assay, respectively. In addition, PC9R cells were transfected with recombinant plasmid pc DNA3.1-BIM and infected with lentivirus of miR-21 interference, then the sensitivity of PC9R cells to gefitinib was detected by CCK-8 assay.Results: After transfection with pc DNA3.1-BIM plasmids, the expression levels of BIM and miR-21 in PC9R cells were increased(P 〈 0.01). After infection of miR-21 expression interference lentivirus, the expression level of miR-21 and BIM in PC9R cells were downregulated(both P 〈 0.05). Both knockdown of miR-21 and over-expression of BIM could improve the sensitivity of PC9R cells to gefitinib(both P 〈 0.05). Moreover, miR-21 knockdown combined with BIM over-expression could further improve the sensitivity of PC9R cells to gefitinib as compared with only miR-21 knockdown group(P 〈 0.05).Conclusion: MiR-21 and BIM may play key roles in the reversal of gefitinib-resistance to EGFR-TKIs, and they have a mutually antagonistic effect.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《肿瘤》
  • 北大核心期刊(2011版)
  • 主管单位:教育部
  • 主办单位:上海市肿瘤研究所
  • 主编:高玉堂
  • 地址:上海斜土路2200弄25号
  • 邮编:200032
  • 邮箱:tumorsci@yahoo.com.cn
  • 电话:021-64436792
  • 国际标准刊号:ISSN:1000-7431
  • 国内统一刊号:ISSN:31-1372/R
  • 邮发代号:4-289
  • 获奖情况:
  • 中文核心期刊,中国科技论文统计源核心期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),英国农业与生物科学研究中心文摘,波兰哥白尼索引,荷兰文摘与引文数据库,荷兰医学文摘,美国剑桥科学文摘,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),瑞典开放获取期刊指南,中国北大核心期刊(2000版)
  • 被引量:19202